E Balzar

1.0k total citations
49 papers, 718 citations indexed

About

E Balzar is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, E Balzar has authored 49 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Pediatrics, Perinatology and Child Health and 12 papers in Surgery. Recurrent topics in E Balzar's work include Renal Transplantation Outcomes and Treatments (12 papers), Dialysis and Renal Disease Management (8 papers) and Organ Transplantation Techniques and Outcomes (7 papers). E Balzar is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Dialysis and Renal Disease Management (8 papers) and Organ Transplantation Techniques and Outcomes (7 papers). E Balzar collaborates with scholars based in Austria, Germany and Canada. E Balzar's co-authors include Christoph Aufricht, Klaus Arbeiter, Gunnar Tydén, Ryszard Grenda, Thomas Mueller, David V. Milford, Nicholas J.A. Webb, Alan R. Watson, Guido Filler and Mary McGraw and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Thrombosis and Haemostasis.

In The Last Decade

E Balzar

49 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Balzar Austria 16 301 198 184 137 124 49 718
A Tarantino Italy 15 445 1.5× 216 1.1× 168 0.9× 129 0.9× 121 1.0× 58 954
H. Prestele Germany 14 407 1.4× 273 1.4× 78 0.4× 78 0.6× 47 0.4× 42 982
J.G Cotorruelo Spain 15 481 1.6× 294 1.5× 188 1.0× 49 0.4× 157 1.3× 50 762
Hans H. Neumayer Germany 14 271 0.9× 243 1.2× 144 0.8× 46 0.3× 61 0.5× 17 932
Olaf Hergesell Germany 15 146 0.5× 117 0.6× 322 1.8× 97 0.7× 51 0.4× 26 874
A. Aroldi Italy 15 333 1.1× 166 0.8× 198 1.1× 145 1.1× 95 0.8× 44 849
Karine Brochard France 12 202 0.7× 248 1.3× 124 0.7× 136 1.0× 39 0.3× 23 794
R. Brunkhorst Germany 17 85 0.3× 110 0.6× 317 1.7× 91 0.7× 79 0.6× 35 885
O Otsubo Japan 14 100 0.3× 108 0.5× 174 0.9× 81 0.6× 67 0.5× 38 512
Birgitta Kranz Germany 15 145 0.5× 95 0.5× 311 1.7× 66 0.5× 86 0.7× 22 618

Countries citing papers authored by E Balzar

Since Specialization
Citations

This map shows the geographic impact of E Balzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Balzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Balzar more than expected).

Fields of papers citing papers by E Balzar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Balzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Balzar. The network helps show where E Balzar may publish in the future.

Co-authorship network of co-authors of E Balzar

This figure shows the co-authorship network connecting the top 25 collaborators of E Balzar. A scholar is included among the top collaborators of E Balzar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Balzar. E Balzar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mueller, Thomas, Klaus Arbeiter, Michael Böehm, et al.. (2006). Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatric Transplantation. 10(5). 565–569. 17 indexed citations
2.
Mueller, Thomas, Klaus Arbeiter, Michael Böehm, et al.. (2006). Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatric Transplantation. 10(4). 474–478. 25 indexed citations
3.
Filler, Guido, Nicholas J.A. Webb, David V. Milford, et al.. (2005). Four‐year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatric Transplantation. 9(4). 498–503. 61 indexed citations
4.
Arbeiter, Klaus, et al.. (2004). ACE inhibition in the treatment of children after renal transplantation. Pediatric Nephrology. 19(2). 222–226. 20 indexed citations
5.
Trompeter, Richard S., Guido Filler, Nicholas J.A. Webb, et al.. (2002). Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatric Nephrology. 17(3). 141–149. 152 indexed citations
6.
Müller, Thomas, et al.. (2001). Low serial serum neopterin does not predict low risk for chronic renal graft rejection. Pediatric Nephrology. 16(1). 11–14. 5 indexed citations
7.
Müller, Thomas, et al.. (2001). Reduction of delayed renal allograft function using sequential immunosuppression. Pediatric Nephrology. 16(8). 613–617. 14 indexed citations
8.
Arbeiter, Klaus, Thomas Mueller, Bettina Bidmon, et al.. (2001). Timing of Peritoneal Dialysis Catheter Removal after Pediatric Renal Transplantation. Peritoneal Dialysis International. 21(5). 467–470. 14 indexed citations
9.
Arbeiter, Klaus, Laurence Greenbaum, E Balzar, et al.. (2000). Reproducible erythroid aplasia caused by mycophenolate mofetil. Pediatric Nephrology. 14(3). 195–197. 29 indexed citations
11.
Kitzmüller, Erwin, et al.. (1997). [Chronic peritoneal dialysis as home therapy in childhood--risks and complications].. PubMed. 109(16). 636–40. 3 indexed citations
12.
Freilinger, Michael, et al.. (1996). [Function and structure of families with chronically ill children].. PubMed. 46(11). 379–84. 2 indexed citations
13.
Kohlhauser, C., E Balzar, Edith Schober, & H Frisch. (1995). Effect of Growth Hormone Treatment on GlucoseTolerance in a Patient with Cystinosis after Kidney Transplantation. Klinische Pädiatrie. 207(3). 106–108. 2 indexed citations
14.
Aufricht, Christoph, et al.. (1995). Formula-Kreatininclearance als Ersatz der 24-Stunden-Kreatininclearance bei nierentransplantierten Kindern. Klinische Pädiatrie. 207(2). 59–62. 5 indexed citations
15.
Balzar, E, et al.. (1986). Quantitative EEG: Investigation in Children with End Stage Renal Disease before and after Haemodialysis. Clinical Electroencephalography. 17(4). 195–202. 12 indexed citations
16.
Pabinger-Fasching, Ingrid, Klaus Lechner, H. Niessner, et al.. (1985). High Levels of Plasma Protein C in Nephrotic Syndrome. Thrombosis and Haemostasis. 53(1). 5–7. 21 indexed citations
17.
Lübec, Gert, et al.. (1978). Urinary excretion ofglomerular basement membrane antigens inAlport's syndrome. 5 indexed citations
18.
Lübec, Gert, et al.. (1978). Urinary excretion of glomerular basement membrane antigens in Alport's syndrome. A new diagnostic approach.. Archives of Disease in Childhood. 53(5). 401–406. 14 indexed citations
19.
Balzar, E, et al.. (1976). [Alport's-syndrome: diagnosis, light- and electronmicroscopic findings (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(1). 221–33. 1 indexed citations
20.
Lübec, Gert, et al.. (1976). [Alpha-1-antitrypsin in children with glomerular diseases (author's transl)].. PubMed. 88(8). 271–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026